Euromedis Groupe (ALEMG.PA)
EUR 3.58
(2.27%)
EUR 3.58
(2.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.8 Million EUR | -14.17% |
| 2022 | 12.59 Million EUR | 7.07% |
| 2021 | 11.76 Million EUR | -54.26% |
| 2020 | 25.71 Million EUR | 41.57% |
| 2019 | 18.16 Million EUR | 15.77% |
| 2018 | 15.68 Million EUR | -10.24% |
| 2017 | 17.47 Million EUR | 27.49% |
| 2016 | 13.7 Million EUR | -2.66% |
| 2015 | 14.08 Million EUR | 5.39% |
| 2014 | 13.36 Million EUR | -1.26% |
| 2013 | 13.53 Million EUR | 2.94% |
| 2012 | 13.14 Million EUR | 2.38% |
| 2011 | 12.84 Million EUR | -10.27% |
| 2010 | 14.31 Million EUR | -3.89% |
| 2009 | 14.88 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 10.05 Million EUR | 0.0% |
| 2023 Q4 | 10.8 Million EUR | 0.0% |
| 2023 Q3 | 10.8 Million EUR | 6.54% |
| 2023 Q2 | 10.14 Million EUR | 0.0% |
| 2023 Q1 | 10.14 Million EUR | -19.43% |
| 2023 FY | 10.8 Million EUR | -14.17% |
| 2022 FY | 12.59 Million EUR | 7.07% |
| 2022 Q3 | 12.59 Million EUR | 45.04% |
| 2022 Q2 | 8.68 Million EUR | 0.0% |
| 2022 Q1 | 8.68 Million EUR | -26.18% |
| 2022 Q4 | 12.59 Million EUR | 0.0% |
| 2021 Q1 | 25.29 Million EUR | -1.6% |
| 2021 FY | 11.76 Million EUR | -54.26% |
| 2021 Q3 | 11.76 Million EUR | -53.52% |
| 2021 Q2 | 25.29 Million EUR | 0.0% |
| 2021 Q4 | 11.76 Million EUR | 0.0% |
| 2020 Q3 | 25.71 Million EUR | 16.78% |
| 2020 Q1 | 22.01 Million EUR | 21.23% |
| 2020 FY | 25.71 Million EUR | 41.57% |
| 2020 Q2 | 22.01 Million EUR | 0.0% |
| 2020 Q4 | 25.71 Million EUR | -0.0% |
| 2019 Q2 | 16.55 Million EUR | 0.0% |
| 2019 Q4 | 18.16 Million EUR | 0.0% |
| 2019 Q3 | 18.16 Million EUR | 9.73% |
| 2019 FY | 18.16 Million EUR | 15.77% |
| 2019 Q1 | 16.55 Million EUR | 0.0% |
| 2018 FY | 15.68 Million EUR | -10.24% |
| 2017 Q1 | 17.47 Million EUR | 7.17% |
| 2017 FY | 17.47 Million EUR | 27.49% |
| 2017 Q4 | 18.68 Million EUR | 0.0% |
| 2017 Q3 | 18.68 Million EUR | 6.93% |
| 2017 Q2 | 17.47 Million EUR | 0.0% |
| 2016 FY | 13.7 Million EUR | -2.66% |
| 2016 Q4 | 16.3 Million EUR | 0.0% |
| 2016 Q1 | 13.7 Million EUR | 3.87% |
| 2016 Q2 | 13.7 Million EUR | 0.0% |
| 2016 Q3 | 16.3 Million EUR | 18.96% |
| 2015 FY | 14.08 Million EUR | 5.39% |
| 2015 Q2 | 14.08 Million EUR | 0.0% |
| 2015 Q1 | 14.08 Million EUR | -13.13% |
| 2015 Q4 | 13.19 Million EUR | 0.0% |
| 2015 Q3 | 13.19 Million EUR | -6.28% |
| 2014 Q4 | 16.21 Million EUR | 0.0% |
| 2014 FY | 13.36 Million EUR | -1.26% |
| 2014 Q2 | 13.36 Million EUR | 1.23% |
| 2014 Q1 | 13.2 Million EUR | -2.3% |
| 2014 Q3 | 16.21 Million EUR | 21.32% |
| 2013 Q2 | 13.53 Million EUR | 0.01% |
| 2013 Q3 | 13.51 Million EUR | -0.16% |
| 2013 Q4 | 13.51 Million EUR | 0.0% |
| 2013 Q1 | 13.53 Million EUR | -5.42% |
| 2013 FY | 13.53 Million EUR | 2.94% |
| 2012 Q1 | 13.14 Million EUR | -12.07% |
| 2012 Q4 | 14.3 Million EUR | 0.0% |
| 2012 Q3 | 14.3 Million EUR | 8.82% |
| 2012 Q2 | 13.14 Million EUR | 0.0% |
| 2012 FY | 13.14 Million EUR | 2.38% |
| 2011 Q3 | 14.95 Million EUR | 16.44% |
| 2011 FY | 12.84 Million EUR | -10.27% |
| 2011 Q4 | 14.95 Million EUR | 0.0% |
| 2011 Q2 | 12.84 Million EUR | 0.0% |
| 2010 Q2 | 14.31 Million EUR | 0.0% |
| 2010 Q4 | 14.24 Million EUR | 0.0% |
| 2010 FY | 14.31 Million EUR | -3.89% |
| 2009 FY | 14.88 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Affluent Medical SA | - EUR | -Infinity% |
| Bluelinea Société Anonyme | 236.08 Thousand EUR | -4477.741% |
| Carmat SA | 23.94 Million EUR | 54.864% |
| Diagnostic Medical Systems S.A. | 16.04 Million EUR | 32.622% |
| Eurobio Scientific Société anonyme | 21.44 Million EUR | 49.613% |
| Ikonisys S.A. | 473.37 Thousand EUR | -2183.044% |
| Implanet S.A. | 3.78 Million EUR | -185.911% |
| Median Technologies SA | 102 Thousand EUR | -10495.541% |
| SpineGuard SA | 950.88 Thousand EUR | -1036.57% |
| Theraclion SA | 3.05 Million EUR | -253.797% |
| Euroapi S.A. | 644.8 Million EUR | 98.324% |
| Guerbet SA | 309.51 Million EUR | 96.508% |